These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8799395)

  • 1. Surgical treatment for gastric carcinomas with concomitant hepatic metastasis.
    Saito A; Korenaga D; Sakaguchi Y; Ohno S; Ichiyoshi Y; Sugimachi K
    Hepatogastroenterology; 1996; 43(9):560-4. PubMed ID: 8799395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in patients with advanced gastric cancer treated by noncurative resection: a multivariate analysis.
    Tsujitani S; Oka S; Suzuki K; Saito H; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Hepatogastroenterology; 2001; 48(41):1504-8. PubMed ID: 11677996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer.
    Saiura A; Umekita N; Inoue S; Maeshiro T; Miyamoto S; Matsui Y; Asakage M; Kitamura M
    Hepatogastroenterology; 2002; 49(46):1062-5. PubMed ID: 12143202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of gastric cancer with concomitant liver metastases.
    Kwok CM; Wu CW; Lo SS; Shen KH; Hsieh MC; Lui WY
    Hepatogastroenterology; 2004; 51(59):1527-30. PubMed ID: 15362793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcome of metachronous hepatic metastases secondary to gastric cancer.
    Choi SB; Song J; Kang CM; Hyung WJ; Kim KS; Choi JS; Lee WJ; Noh SH; Kim CB
    Hepatogastroenterology; 2010; 57(97):29-34. PubMed ID: 20422867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of intraarterial infusion chemotherapy for liver metastasis from gastric cancer FEM: combination therapy of 5-FU, epirubicin and MMC].
    Takada J; Katsuki Y; Hamada H; Tsuji Y
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1627-30. PubMed ID: 14619480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer.
    Sakamoto Y; Sano T; Shimada K; Esaki M; Saka M; Fukagawa T; Katai H; Kosuge T; Sasako M
    J Surg Oncol; 2007 Jun; 95(7):534-9. PubMed ID: 17219383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathological analysis of synchronous liver metastasis in gastric cancer and evaluation of surgical outcomes].
    Li YM; Zhan WH; Han FH; He YL; Peng JS; Cai SR; Ma JP; Zhao G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):127-30. PubMed ID: 16555151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
    Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic studies on gastric cancer with concomitant liver metastases.
    Fujisaki S; Tomita R; Nezu T; Kimizuka K; Park E; Fukuzawa M
    Hepatogastroenterology; 2001; 48(39):892-4. PubMed ID: 11462950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of gastric cancer patients with synchronous hepatic metastasis: a retrospective study.
    Rafique M; Adachi W; Kajikawa S; Kobayashi M; Koike S; Kuroda T
    Hepatogastroenterology; 1995; 42(5):666-71. PubMed ID: 8751232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival after treatment of gastric carcinoma with liver metastases. A case report.
    Das BC; Kawarada Y
    Hepatogastroenterology; 2003; 50(54):2282-4. PubMed ID: 14696518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
    Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of surgical resection for gastric cancer extending to adjacent organs].
    Zhang X; Huang C; Yin F
    Zhonghua Wai Ke Za Zhi; 1995 Oct; 33(10):603-5. PubMed ID: 8731893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of treatment for synchronous hepatic metastases from gastric cancer with special reference to long-term survivors.
    Kunieda K; Saji S; Sugiyama Y; Osada S; Sano J; Nagao N; Takahashi T; Takagi Y; Arai Y
    Surg Today; 2002; 32(7):587-93. PubMed ID: 12111514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial.
    Lygidakis NJ; Sgourakis G; Aphinives P
    Hepatogastroenterology; 1999; 46(27):2035-8. PubMed ID: 10430393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients.
    Sakamoto Y; Ohyama S; Yamamoto J; Yamada K; Seki M; Ohta K; Kokudo N; Yamaguchi T; Muto T; Makuuchi M
    Surgery; 2003 May; 133(5):507-11. PubMed ID: 12773978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors improving survival after gastric and hepatic surgical treatment in gastric cancer patients with synchronous liver metastases.
    Liu J; Li JH; Zhai RJ; Wei B; Shao MZ; Chen L
    Chin Med J (Engl); 2012 Jan; 125(2):165-71. PubMed ID: 22340539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multimodality therapy for synchronous liver metastases of gastric cancer--significance of aggressive hepatic resection of liver lesions].
    Takata N; Harada K; Yoshinaka I; Maeda M; Nasu J; Ikeda R
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1916-9. PubMed ID: 11086445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection.
    Shirabe K; Shimada M; Matsumata T; Higashi H; Yakeishi Y; Wakiyama S; Ikeda Y; Ezaki T; Fukuzawa S; Takenaka K; Kishikawa K; Ikeda T; Taguchi K; Maehara Y; Sugimachi K
    Hepatogastroenterology; 2003; 50(53):1560-3. PubMed ID: 14571786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.